Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cigna Group Director's Dealing 2025

Mar 5, 2025

29918_dirs_2025-03-04_fbded369-8192-4978-a54e-53f916b6456b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2025-02-28

Reporting Person: Cordani David (Director, Chairman & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-28 Common Stock, $.01 Par Value A 49437.0000 $0.0000 Acquired 170783.0000 Direct
2025-02-28 Common Stock, $.01 Par Value A 11117.0000 $0.0000 Acquired 181900.0000 Direct
2025-02-28 Common Stock, $.01 Par Value F 4696.0000 $305.8600 Disposed 177204.0000 Direct
2025-02-28 Common Stock, $.01 Par Value F 22910.0000 $305.8600 Disposed 154294.0000 Direct
2025-03-03 Common Stock, $.01 Par Value S 26527.0000 $308.1200 Disposed 127767.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-28 Employee Stock Option (Right to Buy) $305.8550 A 39476.0000 Acquired 2035-02-28 Common Stock, $.01 Par Value (39476.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, $.01 Par Value 1757.0080 Indirect
Common Stock, $.01 Par Value 334387.0000 Indirect
Common Stock, $.01 Par Value 153801.0000 Indirect

Footnotes

F1: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

F2: Reflects the transfer by the Reporting Person of 334,387 shares of common stock on May 8, 2024 to the Reporting Person's grantor retained annuity trust. In addition, it reflects the transfer by the Reporting Person's grantor retained annuity trust of 99,918 shares of common stock on January 27, 2025 in respect of a payment of an annual annuity to the Reporting Person pursuant to the terms of the grantor retained annuity trust.

F3: These restricted shares vest in three equal annual installments beginning March 1, 2026.

F4: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

F5: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

F6: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2024.

F7: Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

F8: This option vests in three equal annual installments beginning March 1, 2026.